Composites drawn from Elevare engagements. Company details anonymized. Results reflect actual operational improvements, not projections.
The pipeline looked healthy. The forecast said they'd hit the number. Neither was true.
A Series B SaaS company missed two consecutive quarterly forecasts by 20%+. Pipeline showed $4.2M in active opportunities — but 60% hadn't had a meaningful buyer interaction in 30 days. Deal stages were based on rep activity, not buyer progression. The pipeline was full on paper and hollow in practice.
Reviewed every deal against actual buyer engagement signals over 90 days.
Replaced activity-based stage criteria with buyer-action criteria.
Built a forecast model around three leading indicators that correlated with close probability.
Replaced monthly pipeline reviews with weekly 45-minute deal health checks.
Real pipeline dropped from $4.2M to $2.6M — but for the first time, leadership trusted the number. Sales cycle length dropped 41% within one quarter.
"The most valuable thing wasn't the framework. It was finally being able to tell the board what was actually in the pipeline — and have that number mean something."
VP Sales, Series B SaaS
The founder could close anything. The new reps couldn't close much at all.
A $3M professional services firm had grown almost entirely on the founder's sales ability. When he hired two reps, everything he did was undocumented. Six months later, neither had hit their number — and the founder was jumping into every deal himself.
Interviewed the founder across 12 closed deals to extract his actual sales motion.
Translated tacit knowledge into documented stage definitions, qualification criteria, and advancement triggers.
Set up biweekly deal reviews where the founder could coach without taking over.
Both reps hit quarterly targets within 60 days. The founder reduced direct deal involvement by 70% while maintaining growth.
"I'd been selling this way for years and never had to explain it. Once we wrote it down, I realized my reps weren't failing — they just had no idea what I was actually doing."
Founder, Professional Services Firm
The board had stopped trusting the numbers. Leadership had stopped trusting the forecast.
An enterprise B2B tech company missed its annual number two years straight. The forecast had become a weekly negotiation between the CRO and CFO. Reps submitted numbers based on what leadership wanted to see. Nobody trusted the data — including the people producing it.
Analyzed 18 months of deal outcomes to find which pipeline signals correlated with close probability.
Identified three specific situations where forecasts were reliably overstated.
Built a model with automatic probability adjustments — removing human override as the accuracy mechanism.
First quarter on the new model: 96% accuracy. Second quarter: 91%. By year-end, the board stopped requiring weekly overrides and the CRO could use the forecast as an actual planning tool.
"We weren't missing because of the market or the team. We were missing because the forecast was built on hope, not mechanics."
CRO, Enterprise Technology